Revisiting the cutting edge world of Tesla
This post is by Unknown from West Coast Stat Views (on Observational Epidemiology and more)
A couple of months ago, the NYT argued that Elon Musk's long history of cutting corners with respect to ethics and safety was simply the price to be paid for advancing potentially life-saving technology.
Some of Musk’s most questionable decisions, though, begin to make sense if seen as a result of a blunt utilitarian calculus. Last month, Reuters reported that Neuralink, Musk’s medical-device company, had caused the needless deaths of dozens of laboratory animals through rushed experiments. Internal messages from Musk made it clear that the urgency came from the top. “We are simply not moving fast enough,” he wrote. “It is driving me nuts!” The cost-benefit analysis must have seemed clear to him: Neuralink had the potential to cure paralysis, he believed, which would improve the lives of millions of future humans. The suffering of a smaller number of animals was worth it.
There was, as we pointed out at the time, a subtle flaw in that argument.
With the complicated exception of SpaceX, none of Musk's businesses are on the cutting edge of anything. In autonomous driving, AI, solar cell development, brain-machine interfaces, tunneling machines, and countless other technologies where Musk has promised revolutionary disruptions, his companies are, at best, in the middle of the pack and, in some cases, not making any serious effort at all. (On a related note, despite attempts to muddy the waters with creative statistics, Tesla spends far less than any of its major competitors on R&D.)
Now Faiz Siddiqui, writing for (Read more...)